2-haloethylating agents for cancer chemotherapy. 2-haloethyl sulfonates.
Because certain (2-chloroethyl)triazenes and (2-haloethyl)nitrosoureas have high antineoplastic activity, 2-chloroethyl and 2-fluoroethyl sulfonates were prepared to try to develop additional types of 2-haloethylating agents. In this initial study, it was demonstrated that antineoplastic activity much superior to that of the prototype, 2-chloroethyl methanesulfonate, could be found among 2-chloroethyl sulfonates. Among a variety of 2-chloroethyl alkane- and arenesulfonates, several substituted methanesulfonates displayed significant activity against P388 leukemia in mice; the chloromethanesulfonate showed high activity (T/C = 218%). None of the arenesulfonates were active in this test.
D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D007939:Leukemia L1210 / Q000473:pathology; D007941:Leukemia P388 / Q000473:pathology; D051379:Mice; D009150:Mustard Compounds / Q000138:chemical synthesis* / Q000494:pharmacology; D013451:Sulfonic Acids / Q000138:chemical synthesis* / Q000494:pharmacology
D000970:Antineoplastic Agents; D009150:Mustard Compounds; D013451:Sulfonic Acids